EW
insider transactionsEdwards Lifesciences Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-24.2K
0 buy · 24.2K sell
Net value · 30d
-$2.1M
$0 in · $2.1M out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
3
0 buy · 24.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
CEO · 10b5-1
$46.0K
523 sh · $87.92
Own -4%
-
Sell·S
SVP, Corporate Controller
$48.9K
568 sh · $86.08
Own -4%
-
Sell·S
CVP,Strategy/Corp Development
$2.0M
23.1K sh · $86.42
Own -19%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Bernard J Zovighian KEY 10b5-1 | Sell S | 523 | $46.0K |
| May 29, 2026 | Andrew M. Dahl | Sell S | 568 | $48.9K |
| May 27, 2026 | Donald E Bobo JR | Sell S | 23.1K | $2.0M |
About EW insider trading
This page tracks insider transactions for Edwards Lifesciences Corp (EW) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.